Metropolis Healthcare Ltd.

NSE: METROPOLIS | BSE: 542650 | ISIN: INE112L01020 | Industry: Healthcare Services
| Momentum Trap
2050.1000 -29.40 (-1.41%)
NSE Sep 23, 2025 15:49 PM
Volume: 33,977
 

2050.10
-1.41%
Prabhudas Lilladhar
EBITDA loss was reported for April (CY20) We believe METROHL and other organized players that offers tests at premium pricing to be at risk after the lifting of lockdown due to 1) low footfalls triggering revenue loss 2) high operating cost (for COVID compliance) leading to decline in EBITDA/EBITDA margin 3) expected change in spending pattern of consumers (due to challenging demand scenarios) and 4) competitive pricing pressures to maintain market share. These factors may lead to customer preference towards low-cost local and unorganized players....
Metropolis Healthcar.. has an average target of 2114.50 from 4 brokers.
More from Metropolis Healthcare Ltd.
Recommended